• Episode 77: In the Clinic with Professor Naureen Starling discussing metastatic colorectal cancer (part 1)
    Nov 20 2025

    Send us a text

    Show More Show Less
    32 mins
  • Episode 76: Part 2 Discussing Cancer Care in the Transgender Community with Dr Alison Berner
    Nov 13 2025

    Send us a text

    Join us as we return for Part 2 with the superb Dr Alison Berner.

    It’s Transgender Awareness Week and we discuss resources to support patients and clinicians.

    We discuss OUTpatients and UCATS - UK cancer and transition service.



    Show More Show Less
    24 mins
  • Episode 75: Discussing Cancer Care in the Transgender Community with Dr Alison Berner
    Nov 6 2025

    Send us a text

    As we approach transgender awareness week we discuss cancer care in the transgender community with the exceptional Dr Alison Berner.

    1 in 40 people aged under 30 identify as transgender in recent census.

    How we give support needed and signpost patients can have a huge influence on their experience of care.

    Alison has done so much work in this area.

    We learned a lot in this episode and we hope you enjoy!


    https://outpatients.org.uk/

    https://www.wearetransplus.co.uk/uk-cancer-and-transition-service/




    Show More Show Less
    21 mins
  • Episode 74 - In the Clinic: Discussing SABR for Oligoprogression in metastatic prostate cancer with Dr Alison Tree.
    Oct 24 2025

    Send us a text

    We return to discuss stereotactic radiotherapy (SABR) in prostate cancer with the superb Dr Alison Tree from The Royal Marsden Hospital.

    We discuss the findings of the TRAP study which extended time to next treatment by 6 months when SABR was used for sites of growing disease.

    Do we always need to change systemic therapy when only one or two sites of metastatic disease is growing??



    Show More Show Less
    31 mins
  • Episode 73: Influencing the Gut Microbiome in immunotherapy - the CBM 588 story (& beyond) with Professor Monty Pal
    Oct 14 2025

    Send us a text

    We are back for part 2 to finish our journey through the Gut Microbiome with the excellent Professor Monty Pal !!

    Few areas of cancer treatment have generated as much interest as the Gut Microbiome in recent years.

    We discuss work done by Monty's team on CBM588 on immunotherapy in kidney cancer.

    CBM 588 is a live bacterial product that is available in health shops in Japan where it is used to promote a healthy gut.

    Monty's team found incredible results where it improved response rates for immunotherapy containing treatment and significantly improved time to tumour progression.

    Plans are now afoot to trial this in a much larger phase 3 trial which could readout some exciting results!

    We discuss;

    - Should we run patient poo through an AI algorithm to see what gut microbiome changes are needed

    - Can we engineer gut bacteria to make more of useful proteins in our gut

    - Can we get more biotech companies to engage in this space to help move it forward at more pace

    Of course Monty knocks it out of the park so he gets a Simply Oncology wish!!

    Amazing to hear Professor Monty Pal share his thoughts on this exciting area of medicine.

    Show More Show Less
    20 mins
  • Episode 72: The gut microbiome influencing cancer with Professor Monty Pal
    Oct 14 2025

    Send us a text

    Did you know that we have more bacterial DNA than human DNA in our bodies. This is because our guts contain trillions of bacteria and are now being thought of as another organ of the body.

    Join us this week as we discuss the Gut Microbiome (part 1 of 2) and its importance on drugs like immunotherapy response in cancer.

    We talk to none other than the excellent Professor Monty Pal from The City of Hope Hospital in California.

    Monty is an internationally respected kidney cancer expert and has been researching the impact of the gut microbiome on cancer outcomes in recent years.


    We discuss;

    The potential impact of fibre in our diet - any how much that looks like in Wheetabix.

    The need for balanced good versus bad bacteria in our guts.

    That probiotics are not recommended.

    The challenges of a faecal microbiome transplant.

    What a great episode!!

    Show More Show Less
    23 mins
  • Episode 71: Prostate cancer in Black and Ethnic groups with Professor Frank Chinegwundoh
    Oct 6 2025

    Send us a text

    Did you know that the lifetime risk of prostate cancer in a black man is 1 in 4 ?

    That’s twice the risk of prostate cancer in a white man.

    Did you know that men in Scotland are twice as likely to have advanced prostate cancer compared to those in the South of England?

    Professor Frank Chinewungdoh is a man on a mission.

    He is trying to make prostate cancer testing as possible to men across all groups.

    He makes an argument for prostate cancer screening and measures to make PSA testing more accessible.

    Show More Show Less
    35 mins
  • Episode 70: Cancer Vaccines - Challenges & Future Directions with Dr Lennard Lee
    Sep 26 2025

    Send us a text

    We are back to finish our journey through cancer vaccines with Dr Lennard Lee.

    We celebrate some of the heroes of UK cancer vaccine trials from centres Big & Small.

    Lennard gives us all some hope for the future.

    We now are officially Watching This Space for more Cancer Vaccine Trial results.


    Show More Show Less
    21 mins